Scott Ayers

Scott Ayers joined ImmPACT Bio in April 2022 as Head of Quality. Scott has over 25 years of experience in various leadership roles in Quality, Operations and Technology. He has worked in all phases of the product lifecycle from discovery through commercialization at organizations including Amgen, Sanofi, J&J and Merck. Most recently Scott served as Vice President, Operations for Nammi Therapeutics, Inc. where he was responsible for all CMC activities for their Nanotechnology and Immunocytokine platforms. Prior to Nammi Therapeutics, Scott served as Senior Director, Head of Quality, at Agensys/Astellas. His experience spans small molecules, biologics, vaccines, and medical devices. Scott earned his B.A. and M.S. in Statistics at the University of Tennessee.